Patent ductus arteriosus — clinical case

Summary of the case

A thriving four-year-old is referred after a continuous machinery murmur is heard at a routine check. On examination there is a continuous crescendo murmur peaking around the second heart sound at the upper left sternal edge, radiating to the back, with a thrill. The peripheral pulses are bounding and collapsing, and the blood pressure shows a widened pulse pressure with a low diastolic. The child is growing normally and has no symptoms. The echocardiogram confirms a moderate patent ductus arteriosus with continuous left-to-right flow, a left atrial to aortic root ratio of 1.6, a high-velocity restrictive flow pattern, and preserved pulmonary pressures. [1]

Key issues to address

The first issue is confirming that this is an isolated PDA in a structurally normal heart — the safety check that excludes a duct-dependent circulation and coarctation before any closure is planned. The second is grading the haemodynamic burden: this is a moderate duct with a volume-loaded left atrium but preserved, reversible pulmonary pressures, placing it firmly within the operable window. The third is the closure decision itself — whether, when, and how to close — and the fourth is counselling the family on the procedure, the alternatives and the rationale. [1] [5]

Assessment and interpretation

The clinical picture and the echocardiogram agree, which is reassuring. The continuous murmur with bounding pulses and a widened pulse pressure is the bedside signature of a significant left-to-right shunt with diastolic run-off, and the echocardiographic left atrial dilation confirms a haemodynamic burden that warrants closure. The high-velocity restrictive flow pattern confirms that the pulmonary pressure is normal and the duct is within the operable window — the inverse relationship between the duct flow velocity and the aorta-to-pulmonary-artery gradient means a high velocity indicates a large gradient and normal pulmonary pressures. [1]

Management plan

The plan is elective transcatheter device closure with an Amplatzer Duct Occluder as a day-stay procedure. The device, established by the Masura landmark study, is deployed from a femoral venous approach across the duct and achieves closure in over 95% of suitable ducts. The duct's conical (Krichenko type A) morphology is the shape the standard device was designed for, so no alternative device or surgical approach is anticipated. Before the procedure, the structurally normal heart and the preserved pulmonary pressures are reconfirmed. [1] [2]

Risks, complications and counselling

The family is counselled that the procedure is day-stay with a high success rate, and that the alternative of continued observation is reasonable only for a duct with no load — this duct's left atrial dilation tips the balance towards closure. The specific procedural risks are explained: a small residual shunt with haemolysis in the early weeks (usually settling as the device endothelialises), device embolisation (rare and usually retrievable), and in smaller children left pulmonary artery stenosis or aortic coarctation from device protrusion. Routine antibiotic prophylaxis against endocarditis is no longer recommended for the unrepaired PDA, and after successful closure the child returns to normal activity with only routine follow-up. [3] [4]

Prognosis and follow-up

The prognosis after successful closure is excellent — a closed duct is a cured lesion, with no restriction on activity, no need for endocarditis prophylaxis, and routine cardiology follow-up only. The child is reviewed after the procedure to confirm complete occlusion on echocardiography and the absence of device-related obstruction, then discharged to normal care. The expectation the examiner rewards is that a moderate, operable duct closed in childhood carries an essentially normal long-term prognosis, in stark contrast to the late-presenting large duct allowed to cross into Eisenmenger physiology. [1] [5]